SCHEMBL1420985

SCHEMBL1420985

CC(C)(C)n1cc(O)c(CC=O)n1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23400244 0.78
SCHEMBL23400652 0.75
SCHEMBL23401587 0.74 KDM4E (0.40)
SCHEMBL23401047 0.72 NPC1 (0.34)
SCHEMBL23399850 0.69
SCHEMBL23401564 0.67
SCHEMBL23400662 0.66 KDM4E (0.31)
SCHEMBL15435244 0.66 JAK3 (0.37)
SCHEMBL23401132 0.63 GABRA1 (0.35)
SCHEMBL23401916 0.61

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-111574530-B ACC inhibitor and medical application thereof 徐州医科大学 2022-07-26 CN disclosed
CN-111574530-A ACC inhibitor and medical application thereof 徐州医科大学 2020-08-25 CN disclosed
EP-2297164-A1 PYRAZOLOSPIROKETONE ACETYL-COA CARBOXYLASE INHIBITORS Pfizer Inc. (US) 2011-03-23 EP disclosed
WO-2009144555-A1 PYRAZOLOSPIROKETONE ACETYL-COA CARBOXYLASE INHIBITORS PFIZER INC. (US) 2009-12-03 WO disclosed